Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

Similar articles for PubMed (Select 12869559)

1.

Identification of the binding sites of the SR49059 nonpeptide antagonist into the V1a vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensors.

Tahtaoui C, Balestre MN, Klotz P, Rognan D, Barberis C, Mouillac B, Hibert M.

J Biol Chem. 2003 Oct 10;278(41):40010-9. Epub 2003 Jul 17.

2.
3.

Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding.

Cotte N, Balestre MN, Aumelas A, Mahé E, Phalipou S, Morin D, Hibert M, Manning M, Durroux T, Barberis C, Mouillac B.

Eur J Biochem. 2000 Jul;267(13):4253-63.

4.

Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V1a vasopressin receptor.

Breton C, Chellil H, Kabbaj-Benmansour M, Carnazzi E, Seyer R, Phalipou S, Morin D, Durroux T, Zingg H, Barberis C, Mouillac B.

J Biol Chem. 2001 Jul 20;276(29):26931-41. Epub 2001 May 3.

5.

Identification of agonist binding sites of vasopressin and oxytocin receptors.

Mouillac B, Chini B, Balestre MN, Jard S, Barberis C, Manning M, Tribollet E, Trumpp-Kallmeyer S, Hoflack J, Elands J, et al.

Adv Exp Med Biol. 1995;395:301-10.

PMID:
8713980
6.

Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.

Serradeil-Le Gal C, Wagnon J, Valette G, Garcia G, Pascal M, Maffrand JP, Le Fur G.

Prog Brain Res. 2002;139:197-210. Review.

PMID:
12436936
7.

The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues.

Schülein R, Zühlke K, Oksche A, Hermosilla R, Furkert J, Rosenthal W.

FEBS Lett. 2000 Jan 21;466(1):101-6. Erratum in: FEBS Lett 2000 May 4;473(1):124.

8.

A molecular model of agonist and nonpeptide antagonist binding to the human V(1) vascular vasopressin receptor.

Thibonnier M, Coles P, Conarty DM, Plesnicher CL, Shoham M.

J Pharmacol Exp Ther. 2000 Jul;294(1):195-203.

9.

The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions.

Mouillac B, Chini B, Balestre MN, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Jard S, Barberis C.

J Biol Chem. 1995 Oct 27;270(43):25771-7.

10.

Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.

Macion-Dazard R, Callahan N, Xu Z, Wu N, Thibonnier M, Shoham M.

J Pharmacol Exp Ther. 2006 Feb;316(2):564-71. Epub 2005 Oct 18.

11.

Docking of linear peptide antagonists into the human V(1a) vasopressin receptor. Identification of binding domains by photoaffinity labeling.

Phalipou S, Seyer R, Cotte N, Breton C, Barberis C, Hibert M, Mouillac B.

J Biol Chem. 1999 Aug 13;274(33):23316-27.

12.

Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonist.

Phalipou S, Cotte N, Carnazzi E, Seyer R, Mahe E, Jard S, Barberis C, Mouillac B.

J Biol Chem. 1997 Oct 17;272(42):26536-44.

13.

Biological characterization of rodent and human vasopressin V1b receptors using SSR-149415, a nonpeptide V1b receptor ligand.

Serradeil-Le Gal C, Raufaste D, Derick S, Blankenstein J, Allen J, Pouzet B, Pascal M, Wagnon J, Ventura MA.

Am J Physiol Regul Integr Comp Physiol. 2007 Aug;293(2):R938-49. Epub 2007 May 23.

14.

Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes.

Serradeil-Le Gal C, Raufaste D, Marty E, Garcia C, Maffrand JP, Le Fur G.

Biochem Biophys Res Commun. 1994 Feb 28;199(1):353-60.

PMID:
8123034
15.

Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.

Postina R, Kojro E, Fahrenholz F.

Adv Exp Med Biol. 1998;449:371-85. Review.

PMID:
10026828
16.

Synthetic rat V1a vasopressin receptor fragments interfere with vasopressin binding via specific interaction with the receptor.

Mendre C, Dufour MN, Le Roux S, Seyer R, Guillou L, Calas B, Guillon G.

J Biol Chem. 1997 Aug 22;272(34):21027-36.

17.

Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059.

Serradeil-Le Gal C, Raufaste D, Marty E, Garcia C, Maffrand JP, Le Fur G.

Kidney Int. 1996 Aug;50(2):499-505.

PMID:
8840278
18.

Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells.

Chiang N, Kan WM, Tai HH.

Arch Biochem Biophys. 1996 Oct 1;334(1):9-17.

PMID:
8837733
19.

Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.

Chini B, Mouillac B, Ala Y, Balestre MN, Cotte N, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, et al.

Adv Exp Med Biol. 1995;395:321-8.

PMID:
8713982
20.

Molecular pharmacology and modeling of vasopressin receptors.

Thibonnier M, Coles P, Thibonnier A, Shoham M.

Prog Brain Res. 2002;139:179-96. Review.

PMID:
12436935
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk